STOCK TITAN
  1. Home
  2. Sec-filings
  3. VC
  4. [Form 4] VISTEON CORPORATION Insider Trading Activity

VC Form 4: Senior VP Vallance Sells 2,000 Shares Under 10b5-1 Plan

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Robert R. Vallance, Senior Vice President of Visteon Corporation (VC), reported a sale of 2,000 shares of the company's common stock on 08/13/2025 at a price of $120 per share. After the transaction, he beneficially owned 18,838 shares directly. The filing states the trades were executed under a Rule 10b5-1 trading plan that Vallance adopted on March 5, 2025. The Form 4 was signed on behalf of the reporting person on 08/14/2025. The report identifies Vallance as an officer (Senior Vice President) and was filed as an individual Form 4.

Positive

  • Transaction executed under a Rule 10b5-1 plan, which provides an established framework for pre-scheduled trades
  • Clear disclosure of transaction date, price, and post-transaction beneficial ownership

Negative

  • Officer disposition of 2,000 shares could be viewed negatively by some investors despite being under a trading plan

Insights

TL;DR: Officer sold 2,000 shares under a pre-established 10b5-1 plan; filing shows routine insider disposition.

This Form 4 documents a single non-derivative disposition by a named officer. The sale was executed pursuant to a Rule 10b5-1 trading plan adopted March 5, 2025, which typically provides an affirmative defense against insider trading claims when conditions are met. The filing reports the post-transaction direct beneficial ownership as 18,838 shares, which contextualizes the size of the sale relative to holdings but does not disclose the officer's total compensation or other holdings.

TL;DR: Disclosure is clear and includes 10b5-1 plan reference; procedural signature completed by corporate secretary.

The Form 4 includes required elements: transaction date, amount sold, price, ownership after sale, relationship to issuer (Senior Vice President), and an explanation noting the 10b5-1 plan adoption date. The form was signed by the corporate secretary on behalf of the reporting person, indicating proper execution. No amendments or additional derivative transactions are reported.

Insider Vallance Robert R
Role Senior Vice President
Sold 2,000 shs ($240K)
Type Security Shares Price Value
Sale Common Stock 2,000 $120.00 $240K
Holdings After Transaction: Common Stock — 18,838 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vallance Robert R
(Last) (First) (Middle)
VISTEON CORPORATION
ONE VILLAGE CENTER DRIVE
(Street)
VAN BUREN TOWNSHIP MI 48111
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VISTEON CORP [ VC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/13/2025 S(1) 2,000 D $120 18,838 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2025.
Remarks:
/s/Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Robert R. Vallance 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Robert R. Vallance report in the Form 4 for Visteon (VC)?

He reported a sale of 2,000 shares of Visteon common stock on 08/13/2025 at $120 per share and now directly owns 18,838 shares.

Was the sale by the Visteon officer part of a 10b5-1 plan?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025.

What is Robert R. Vallance's role at Visteon according to the filing?

The filing identifies him as a Senior Vice President of Visteon Corporation.

When was the Form 4 signed and who signed it?

The Form 4 was signed on behalf of Robert R. Vallance by Heidi A. Sepanik, Corporate Secretary on 08/14/2025.

How many shares does Vallance own after the reported transaction?

Following the reported sale, he beneficially owns 18,838 shares directly.